Zobrazeno 1 - 10
of 34
pro vyhledávání: '"M.-S. Fangous"'
Autor:
P. Martinet, L. Khatchatourian, N. Bizien, F. Le Gall, M-S Fangous, P. Vic, D. Goulon, J-P. Talarmin
Publikováno v:
Médecine et Maladies Infectieuses Formation. 2:32-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c5512d595ec9bcd0e85e5a32761ebce
https://doi.org/10.1016/j.mmifmc.2022.10.001
https://doi.org/10.1016/j.mmifmc.2022.10.001
Autor:
B, Guerpillon, M S, Fangous, E, Le Breton, M, Artus, F, le Gall, L, Khatchatourian, J P, Talarmin, P, Plesiat, K, Jeannot, N, Saidani, G, Rolland-Jacob
Publikováno v:
Infectious Diseases Now. 52:299-303
We report an outbreak of Elizabethkingia anophelis infections in France. To the best of our knowledge, this is the first outbreak described in Europe.Each E. anophelis-positive microbiological sample was considered a case. All patients were hospitali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be9149a2047298d1ffbc99be2ad4f48
https://doi.org/10.1016/j.idnow.2022.05.005
https://doi.org/10.1016/j.idnow.2022.05.005
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Beneficial Microbes
Beneficial Microbes, Wageningen Academic Publishers 2019, 10 (8), pp.893-900. ⟨10.3920/BM2019.0069⟩
Beneficial Microbes, Wageningen Academic Publishers 2019, 10 (8), pp.893-900. ⟨10.3920/BM2019.0069⟩
WOS:000501544400007; International audience; The spreading of antibiotic resistance is a major public health issue, which requires alternative treatments to antibiotics. Lactobacilli have shown abilities to prevent pneumonia in clinical studies when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc060ababe1051648187c04b338f4a6
https://doi.org/10.3920/bm2019.0069
https://doi.org/10.3920/bm2019.0069
Autor:
Philippe Gosset, Christopher Payan, Charles-Antoine Guilloux, M.-S. Fangous, Rozenn Le Berre, S. Vallet, S. Gouriou, Nicolas Galakhoff, Geneviève Héry-Arnaud
Publikováno v:
BMC Microbiology
BMC Microbiology, BioMed Central, 2021, 21 (1), pp.195. ⟨10.1186/s12866-021-02254-7⟩
BMC Microbiology, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Microbiology, 2021, 21 (1), pp.195. ⟨10.1186/s12866-021-02254-7⟩
BMC Microbiology, BioMed Central, 2021, 21 (1), pp.195. ⟨10.1186/s12866-021-02254-7⟩
BMC Microbiology, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Microbiology, 2021, 21 (1), pp.195. ⟨10.1186/s12866-021-02254-7⟩
Background : Increasing resistance to antibiotics of Pseudomonas aeruginosa leads to therapeutic deadlock and alternative therapies are needed. We aimed to evaluate the effects of Lactobacillus clinical isolates in vivo, through intranasal administra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c77df13fd7f82272163e9b3cce1ff51e
https://doi.org/10.1186/s12866-021-02254-7
https://doi.org/10.1186/s12866-021-02254-7
Publikováno v:
Beneficial microbes. 10(8)
The spreading of antibiotic resistance is a major public health issue, which requires alternative treatments to antibiotics. Lactobacilli have shown abilities to prevent pneumonia in clinical studies when given by oral route, certainly through the gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa63d39a205ccc342c732e311f871758
https://pubmed.ncbi.nlm.nih.gov/31965833
https://pubmed.ncbi.nlm.nih.gov/31965833
Autor:
R. Gorton, C. Mediavilla-Gradolph, Brigid Lucey, D. Orth-Höller, J. van Ingen, Germán Bou, Gilbert Greub, Pieter-Jan Ceyssens, Griselda Tudó, Jim O'Mahony, David Rodriguez-Temporal, Belén Rodríguez-Sánchez, A.B. Pranada, María Jesús Ruiz-Serrano, Fernando Alcaide, Daniel Corcoran, Marina Oviaño, I. González-Álvarez, I. Marekoviċ, Juan-José Palacios, Onya Opota, J. Hrábak, J. Amlerová, A. Van den Bossche, B. O'Reilly, André Ingebretsen, James O’Connor, Geneviève Héry-Arnaud, L. Quiroga, Pere Coll, B. Palop, M.R. Monté, M.-S. Fangous
Publikováno v:
Clinical Microbiology and Infection, 24, 6, pp. 599-603
Clinical Microbiology and Infection, 24, 599-603
Clinical Microbiology and Infection, 24, 599-603
Item does not contain fulltext BACKGROUND: The implementation of MALDI-TOF MS for microorganism identification has changed the routine of the microbiology laboratories as we knew it. Most microorganisms can now be reliably identified within minutes u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139762fca2a1669001f0e4b7da7d773f
https://doi.org/10.1016/j.cmi.2017.11.012
https://doi.org/10.1016/j.cmi.2017.11.012
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Geneviève Héry-Arnaud, Charles-Antoine Guilloux, P. Gosset, S. Gouriou, S. Vallet, M.-S. Fangous, R. Lagrafeuille, R. Le Berre
Publikováno v:
Revue des Maladies Respiratoires. 38:583
Introduction In CF patients, PA chronic lung infections combined with acquisition of antibiotics resistance leads to therapeutic deadlock. Among non-antibiotic alternative, the use of Lactobacilli is promising since its oral administration (OA) stimu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea0c7c1333257ec085955577c417b30e
https://doi.org/10.1016/j.rmr.2021.02.032
https://doi.org/10.1016/j.rmr.2021.02.032